Open session of the standing technical committee of the EUFMD- 2004

Page 236

Appendix 36 Moving towards a better understanding of airborne transmission of FMD John Gloster1*, Isabel Esteves 2 and Soren Alexandersen 1

3

Met Office, UK, based at Pirbright Laboratory, Institute for Animal Health, Ash Rd, Woking, Surrey, GU24 0NF, UK 2 Pirbright Laboratory, Institute for Animal Health, Ash Rd, Woking, Surrey, GU24 0NF, UK 3 Danish Institute for Food and Veterinary Research, Department of Virology, Lindholm, DK-4771 Kalvehave, Denmark

Abstract In the event of an outbreak of FMD it is essential for those responsible for controlling and eradicating the disease to quickly assess how the initial animals became infected and its potential for further spread. Once this has been determined the appropriate control measures can be introduced. It has been established that airborne transmission of FMD virus is one of the mechanisms by which disease is transmitted and consequently it is important to develop a capability by which this can be rapidly assessed. This often involves the integration of epidemiological data collected in the field, laboratory investigations and the use of a transport and dispersion model. Before an accurate prediction of airborne spread can be made it is of vital importance to understand each part of the disease chain together with its errors and uncertainties. How the model then represents the data is also key to obtaining a good estimate of disease spread. This paper identifies the key components in the models and identifies current errors and uncertainties. Introduction Laboratory and epidemiological studies have identified airborne transmission of FMD virus as one of the mechanisms by which disease is transmitted (reviewed by Alexandersen et al. 2003). A number of field studies have indicated that airborne virus was the most likely mechanism for disease transmission over many tens of km over land and several occasions involving a hundred or more km over the sea (Hugh-Jones and Wright 1970; Sellers and Foreman 1973; Donaldson et al. 1982; Sørensen et al. 2000; Gloster et al. 2003; Mikkelsen et al. 2003). In principle the airborne disease cycle is easy to understand (emission, transport and infection). However, in practice the inter-relation is far more complex and requires the use of a computer model to assess the potential for disease spread. For example, virus emission rates depend critically on the species involved, the stage of disease and the meteorological conditions. The meteorological conditions may vary significantly throughout one day, let alone over a typical period of virus emission (often a number of days). Definition of areas of risk is often made more difficult in areas of complex topography. The quality of an assessment of airborne transmission will only be as good as the input data and the assumptions and formulation of the model. Inaccurate model output may be misleading or wrong and any operational decisions taken on the strength of it flawed. Consequently it is important to have a detailed understanding of the quality and representivity model input data and how the model handles this information. Materials and Methods There are a number of atmospheric transport and dispersion models in use at centres around the world and potentially there are numerous combinations of inputs, outputs and degree of integration into decision support models (Sørensen 1998; Sanson, Morris and Stern 1999; Sørensen et al. 2000; Sørensen et al. 2001; Morris et al. 2002; Gloster et al. 2003). However, in general they all conform to a similar generic structure. This structure is used as the basis for assessing our current understanding and ability to predict airborne transmission of FMD. Results - Disease transmission and model representation Atmospheric transport and dispersion models are supplied with two major inputs; epidemiological to determine source terms and virus characteristics and meteorological data for virus transport. The output is typically presented in terms of virus concentration as a function of distance from the source. If a Graphical Interface System (GIS) is available other relevant data e.g. livestock distribution can also be presented simultaneously. 227


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Appendix 82

17min
pages 492-500

Appendix 77

22min
pages 468-476

Appendix 78

25min
pages 477-484

Appendix 79

14min
pages 485-489

Appendix 81

1min
page 491

Appendix 80

1min
page 490

Appendix 76

12min
pages 464-467

Appendix 75

1min
page 463

Appendix 64

10min
pages 412-414

Appendix 72

13min
pages 455-460

Appendix 73

1min
page 461

Appendix 65

1min
page 415

Appendix 67

1min
page 424

Appendix 63

34min
pages 401-411

Appendix 62

2min
page 400

Appendix 54

8min
pages 361-363

Appendix 61

15min
pages 394-399

Appendix 55

11min
pages 364-366

Appendix 59

1min
page 385

Appendix 60

20min
pages 386-393

Appendix 56

1min
page 367

Appendix 42

21min
pages 270-276

Appendix 52

10min
pages 350-352

Appendix 50

21min
pages 330-339

Appendix 46

2min
page 307

Appendix 37

7min
pages 241-243

Appendix 38

7min
pages 244-246

Appendix 41

2min
page 269

Appendix 40

15min
pages 255-268

Appendix 36

16min
pages 236-240

Appendix 35

15min
pages 231-235

Appendix 34

25min
pages 224-230

Appendix 28

2min
page 198

Appendix 31

10min
pages 212-215

Appendix 29

16min
pages 199-203

Appendix 33

3min
pages 221-223

Appendix 27

1min
page 197

Appendix 26

27min
pages 188-196

Appendix 25

12min
pages 182-187

Appendix 23

8min
pages 168-171

Appendix 22

28min
pages 158-167

Appendix 15

2min
page 113

Appendix 16

7min
pages 114-116

Appendix 20 EMEA paper extract - Recommendations for tests for induction of antibodies to NSP antigens by FMD vaccines

4min
pages 144-145

Appendix 19

18min
pages 136-143

Appendix 14

4min
page 112

Appendix 13

10min
pages 107-111

Appendix 5

2min
page 64

Appendix 12

9min
pages 104-106

Appendix 3

9min
pages 47-49

Appendix 4

26min
pages 50-63

Appendix 8

12min
pages 77-80

Appendix 2

8min
pages 43-46

Open Session

6min
pages 39-42

Closed Session

2min
pages 37-38

Item 11 – Persistent and subclinical infections – diagnostic and surveillance issues

3min
page 33

Item 15 – Managing the decision-making process in control of FMD and in the priority setting of research and development

3min
page 36

Item 14 – Regulatory compliance

2min
page 35

Item 10 – International issues

3min
page 32

Item 9 – Novel vaccines

3min
page 31

Item 7 – Optimisation of conventional vaccines

3min
page 29

Item 4 – Managing diagnostic demands

3min
page 27

Item 8 – Regulatory issues affecting FMD vacine selection and use

3min
page 30

Item 3 – Transmission and its control

3min
page 26

3.4.2 Post-vaccination serosurveillance (PVS) for presence of FMD infected animals

3min
page 16

Item 1 – Recent findings in molecular epidemiology of FMDV

3min
page 24

Item 2 – Surveillance: for what purpose and how much is enough?

3min
page 25

4.2 Collection of sera/specimens for validation of DIVA tests for detection of animals received from SAT virus infection

3min
page 20
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.